Methylphenidate Treatment and Risk of Psychotic Disorder.

Healy C, O'Hare K, Lång U, Metsälä J, Pulakka A, McGrath J, Migone M, Keating D, Romaniuk L, Gyllenberg D, Kajantie E, Perrett G, Hill J, Elwert F, Kelleher I

Open source

DOI
10.1001/jamapsychiatry.2026.0152
Published
2026 Jun 1
Container
JAMA psychiatry
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamapsychiatry.2026.0152,
  title = {Methylphenidate Treatment and Risk of Psychotic Disorder.},
  author = {Healy C and O'Hare K and Lång U and Metsälä J and Pulakka A and McGrath J and Migone M and Keating D and Romaniuk L and Gyllenberg D and Kajantie E and Perrett G and Hill J and Elwert F and Kelleher I},
  year = {2026},
  journal = {JAMA psychiatry},
  doi = {10.1001/jamapsychiatry.2026.0152},
  url = {https://doi.org/10.1001/jamapsychiatry.2026.0152}
}

RIS

TY  - JOUR
TI  - Methylphenidate Treatment and Risk of Psychotic Disorder.
AU  - Healy C
AU  - O'Hare K
AU  - Lång U
AU  - Metsälä J
AU  - Pulakka A
AU  - McGrath J
AU  - Migone M
AU  - Keating D
AU  - Romaniuk L
AU  - Gyllenberg D
AU  - Kajantie E
AU  - Perrett G
AU  - Hill J
AU  - Elwert F
AU  - Kelleher I
PY  - 2026
JO  - JAMA psychiatry
DO  - 10.1001/jamapsychiatry.2026.0152
UR  - https://doi.org/10.1001/jamapsychiatry.2026.0152
ER  - 

APA

C, H., K, O., U, L., J, M., A, P., J, M., M, M., D, K., L, R., D, G., E, K., G, P., J, H., F, E., & I, K. (2026). Methylphenidate Treatment and Risk of Psychotic Disorder.. JAMA psychiatry. https://doi.org/10.1001/jamapsychiatry.2026.0152

Source records